Clinical Characteristics and Treatment Patterns in Patients with Pulmonary Arterial Hypertension (PAH) Initiating Selexipag in the EXPOSURE Observational Study

被引：0
|
作者：
Lange, T. J. [1 ]
Escribano, P. [2 ]
Biedermann, P. [3 ]
Muller, A. [3 ]
Sun, H. [3 ]
Soderberg, S. [4 ]
Gaine, S. [5 ]
机构：
[1] Univ Med Ctr Regensburg, Internal Med 2, Regensburg, Germany
[2] Hosp 12 Octubre, CIBERCV, Dept Cardiol, Pulm Hypertens Unit, Madrid, Spain
[3] Actel Pharmaceut Ltd, Allschwil, Switzerland
[4] Umea Univ, Cardiol & Heart Ctr, Dept Publ Hlth & Clin Med, Umea, Sweden
[5] Mater Misericordiae Univ Hosp, Dublin, Ireland
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2020年 / 201卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A2910
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Outcomes of selexipag for treatment of pulmonary arterial hypertension in an Asian population
    Loo, Germaine
    Yap, Jonathan
    Hon, Jin Shing
    Ismail, Aidila
    Ruan, Wen
    Low, Andrea
    Lim, Soo Teik
    Tan, Ju Le
    ANNALS ACADEMY OF MEDICINE SINGAPORE, 2023, 52 (04) : 219 - 221
  • [42] CHARACTERISTICS OF PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION RECEIVING SELEXIPAG IN THE SPHERE REGISTRY BY RACE AND ETHNICITY
    Farber, Harrison
    Chakinala, Murali M.
    Hemnes, Anna R.
    Chin, Kelly
    Highland, Kristin B.
    McLaughlin, Vallerie
    Melendres-Groves, Lana
    Cho, Michelle
    Doad, Gurinderpal
    Fatehi, Elham
    Han, Michelle
    Rahman, Mohammad
    Strachan, Paul M.
    Tobore, Tobore
    Kim, Nick H.
    CHEST, 2023, 164 (04) : 5952A - 5956A
  • [43] Selexipag treatment in patients with systemic sclerosis-associated pulmonary arterial hypertension in clinical practice, a case series
    Lemmers, Jacqueline M. J.
    Fretheim, Havard
    Knaapen, Hanneke K. A.
    van den Hoogen, Frank H. J.
    Van Haren-Willems, Jolanda H. G. M.
    Duijnhouwer, Anthony L.
    van Dijk, Arie P.
    van den Ende, Cornelia H. M.
    Hoffmann-Vold, Anna-Maria
    Vonk, Madelon C.
    JOURNAL OF SCLERODERMA AND RELATED DISORDERS, 2020, 5 (03) : NP7 - NP11
  • [44] Baseline history of patients using selexipag for pulmonary arterial hypertension
    Highland, Kristin B.
    Hull, Michael
    Pruett, Janis
    Elliott, Caitlin
    Tsang, Yuen
    Drake, William
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2019, 13
  • [45] DEMOGRAPHICS, CLINICAL CHARACTERISTICS, AND TREATMENT PATTERNS OF PATIENTS NEWLY STARTED ON PROSTACYCLIN THERAPY FOR PULMONARY ARTERIAL HYPERTENSION
    Rotella, P.
    Schneider, G.
    Raspa, S.
    Berger, A.
    Pruett, J.
    Murphy, B.
    Lickert, C.
    Drake, W.
    VALUE IN HEALTH, 2015, 18 (07) : A379 - A379
  • [46] Pharmacokinetic drug evaluation of selexipag for the treatment of pulmonary arterial hypertension
    Sardana, Mayank
    Moll, Matthew
    Farber, Harrison W.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2016, 12 (12) : 1513 - 1520
  • [47] Selexipag Dosing Strategies for Pediatric Patients with Pulmonary Arterial Hypertension
    Grossman, Madeline
    Walker, Stephen
    Ramsey, E. Zachary
    PEDIATRIC CARDIOLOGY, 2024, : 902 - 907
  • [48] Modern Treatment Patterns in Incident Pulmonary Arterial Hypertension (PAH) Patients: RealWorld Data From the Pulmonary Hypertension Association (PHA) Registry
    Paoli, Carly J.
    Kime, Noah
    Williams, Kayleen
    Gomez-Rendon, Gabriela
    Tonelli, Adriano
    Cajigas, Hector
    Mathai, Stephen
    Khan, Sarah L.
    Sahay, Sandeep
    CIRCULATION, 2023, 148
  • [49] Effect of riociguat on pulmonary arterial compliance in patients with pulmonary arterial hypertension (PAH) in the RESPITE study
    Hoeper, Marius M.
    Corris, Paul A.
    Ghofrani, Hossein-Ardeschir
    Klinger, James R.
    Langleben, David
    Naeije, Robert
    Simonneau, Gerald
    Jansa, Pavel
    Rosenkranz, Stephan
    Grunig, Ekkehard
    Scelsi, Laura
    Meier, Christian
    Busse, Dennis
    Benza, Raymond L.
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [50] Effect of Riociguat on Pulmonary Arterial Compliance in Patients With Pulmonary Arterial Hypertension (PAH) in the Respite Study
    Thenappan, Thenappan
    Hoeper, Marius
    Corris, Paul
    Ghofrani, Hossein-Ardeschir
    Klinger, James
    Langleben, David
    Naeije, Robert
    Simonneau, Gerald
    Jansa, Pavel
    Rosenkranz, Stephan
    Grunig, Ekkehard
    Scelsi, Laura
    Meier, Christian
    Busse, Dennis
    Benza, Raymond
    CHEST, 2017, 152 (04) : 1005A - 1006A
12345